PCVX Sale Disclosure
Cowan Elvia · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$36.07K
Cowan Elvia SVP, Finance & CAO
PCVX
Vaxcyte
PCVX
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
PCVX daily price context
Close on/before transaction
$60.62
Nov 2, 2026
First close after public filing
$61.92
Nov 5, 2026
Return after filing · so far
+3.18%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 586 shares @ $61.55
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001960048-26-000015
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$260.51K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX | Exercise | Nov 2, 2026 | $77.76K |
| Vaxcyte, Inc. PCVX | Sale | Nov 2, 2026 | $146.69K |
| Vaxcyte, Inc. PCVX Current | Sale | Nov 2, 2026 | $36.07K |
| Vaxcyte, Inc. PCVX | Exercise | Nov 2, 2026 | $0 |